Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02022410
Other study ID # CHUV 144/13
Secondary ID CAS
Status Completed
Phase N/A
First received September 17, 2013
Last updated June 1, 2015
Start date September 2013
Est. completion date June 2015

Study information

Verified date June 2015
Source University of Lausanne Hospitals
Contact n/a
Is FDA regulated No
Health authority Switzerland: Swissmedic
Study type Observational [Patient Registry]

Clinical Trial Summary

The purpose of the study is to prospectively evaluate patients who underwent total knee arthroplasty (TKA) using the Cumulated Ambulation Score (CAS)


Description:

The number of patients who receive a total knee arthroplasty (TKA) is steadily increasing and although the reliability and the results of this procedure are excellent, intensive functional rehabilitation is needed postoperatively to obtain satisfactory range of motion. Currently, the standard length of stay at our hospital is between 8 and 10 days for patients who undergo TKA.

The length of stay depends not only on factors such as early mobilization, pain management, major or minor complications and logistical or organizational problems (1) (2). It also depends on the availability of adequate services when the patient needs to be transferred to an appropriate facility. Each of these steps can be further developed in order to improve the quality of care for patients, reduce hospital costs and increase the availability of beds (3). As a result, the reduction in average length of stay would not only result in a reduction in cost but also a greater turnover in the number of patients. Several studies show that the application of a post-operative fast-track strategy may reduce the length of stay in a very significant manner with benefit for patients and hospitals (3).Thus, if their condition allows, patients would have rapid post-operative rehabilitation, with early joint mobilization at D0 (operative day) and walking from D1 (the first post-operative day).

The Cumulated Ambulation Score (CAS) (4) is a tool developed and tested for initial predicting the in-patient length of stay following a hip surgery. The CAS consists of documenting the patient's ability and independence while performing 3 basic daily activities (sit to stand, transfer out of bed and mobilization). It is calculated using a score of 0-2 for each parameter, giving a total daily score of 0 to 6 and a score of 0 to 18 during the first 3 post-operative days. The CAS is then the sum of scores of the first 3 post-operative days. This score proves to be an effective tool for predicting the length of stay, and other parameters investigated such as survival rate and return home after a proximal femoral surgery.


Recruitment information / eligibility

Status Completed
Enrollment 73
Est. completion date June 2015
Est. primary completion date September 2014
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria: Adults after elective TKA -

Exclusion Criteria: No consent form signed, neurological impairment

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Intervention

Other:
CAS after primary and revision TKA
CAS and RAPT

Locations

Country Name City State
Switzerland CHUV - Hopital Orthopedique Lausanne Vaud

Sponsors (1)

Lead Sponsor Collaborator
University of Lausanne Hospitals

Country where clinical trial is conducted

Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Other Destination at the end of the hospitalisation Record the patients' destination at the end of the in-hospital stay: home, rehabilitation centre, residential home or other. at the moment of departure from in-hospital care No
Primary CAS value Record the CAS values for the first three operative days as mentioned in the protocol The 3rd day after TKA No
Secondary Length of stay Record number of in-hospital days between 4 days and 2 weeks No
See also
  Status Clinical Trial Phase
Completed NCT04825145 - Preeclampsia and Contact Activation